Societal CDMO Inc (NASDAQ:SCTL)
| 1.66 Delayed Data As of 3:59pm ET |  +0.08 / +5.06%Today’s Change | 0.62 Today|||52-Week Range 2.19 | -2.92% Year-to-Date |
Latest SCTL News | Press Releases
No recent news for Societal CDMO Inc.
Today’s Trading
| Previous close | 1.58 |
| Today’s open | 1.60 |
| Day’s range | 1.60 - 1.70 |
| Volume | 1,425 |
| Average volume (3 months) | 114,646 |
| Market cap | $92.9M |
Data as of 3:59pm ET, 10/04/2022
Growth & Valuation
| Earnings growth (last year) | +77.75% |
| Earnings growth (this year) | +8.65% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +13.33% |
| P/E ratio | NM |
| Price/Sales | 1.00 |
| Price/Book | 1.82 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SESNSesen Bio Inc | +0.06 | +12.79% |
| DAREDare Bioscience Inc | +0.01 | +1.44% |
| FBIOFortress Biotech Inc | +0.01 | +0.81% |
| OCXOncoCyte Corp | +0.01 | +1.69% |
Data as of 4:00pm ET, 10/04/2022
Financials
| Next reporting date | November 10, 2022 |
| EPS forecast (this quarter) | -$0.06 |
| Annual revenue (last year) | $75.4M |
| Annual profit (last year) | -$11.4M |
| Net profit margin | -15.09% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Exton, Pennsylvania |
Forecasts
